Legend Biotech Corp. (LEGN) PT Lowered to $78 at Barclays
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Price: $17.61 +0.17%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $78.00 (from $80.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Beijer Ref AB (BEIJB:SS) PT Raised to SEK150 at Citi
- China Cinda Asset Management (1359:HK) PT Lowered to HK$0.95 at JPMorgan
- Takeda Pharmaceutical (4502:JP) (TAK) PT Raised to JPY7,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
